Shares of Cronos Group (NASDAQ: CRON) were sinking 4.1% lower as of 10:57 a.m. ET on Tuesday and fell as much as 5.7% earlier in the day. The decline came after the U.S. Drug Enforcement ...

Analysts covering Cronos Group are centering their views around a CA$4.50 price target and a CA$4.235 fair value estimate that remains unchanged, putting the current debate squarely on how the stock ...

Cronos Group’s smaller size and production capacity would be less of an issue if its market cap were not the third largest of firms listed in Figure 5. This lofty valuation makes it even harder for ...

Cronos Group (NASDAQ: CRON) stock jumped 9.4% through 11:30 a.m. ET Tuesday after beating Wall Street forecasts for Q3 earnings this morning. Heading into the report, analysts expected Cronos to do ...

Aurora Cannabis, Cronos, SNDL, and Canopy Growth recently reported earnings. Tilray reported last month. Village Farms will report this week. So far, cannabis companies have shown strong quarterly ...

Shares of Cronos Group (CRON) rose on Thursday after its revenue growth in the second quarter report offset effects of a results miss. The cannabis company posted a 20.5% rise in quarterly revenue to ...

Shares of Cronos Group Inc. CRON slipped 1.14% to $2.60 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index COMP falling 1.02% to ...

Cronos Group Inc (NASDAQ:CRON) reported first-quarter financial results ahead of the market open Thursday. Here’s a look at the key highlights from the cannabis company’s report. Q1 Revenue: Cronos ...

Cronos was supposed to lose money in Q3. It earned a profit instead. The company's management declined to promise a full-year profit, however. And most analysts expect Cronos to resume losing money -- ...